论文部分内容阅读
前列腺癌的ＤＮＡ倍体与其生物学行为相关 ,有人认为从细针活检标本中得到的ＤＮＡ倍体可能比Ｇｌｅａｓｏｎ评分更能准确地预测前列腺癌的分期分级。我们对ＪｏｈｎｓＨｏｐｋｉｎｓ医院 1994～ 1997年收冶的 15 9例前列腺癌患者的临床资料进行了回顾性研究 ,比较ＤＮＡ倍体与
DNA ploidy of prostate cancer is related to its biological behavior, and it is thought that DNA ploidy obtained from fine-needle biopsy specimens may predict staging of prostate cancer more accurately than Gleason score. We retrospectively reviewed the clinical data of 159 prostate cancer patients recruited at Johns Hopkins Hospital from 1994 to 1997. We compared DNA ploidy with